Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

被引:10
作者
Ravi, R
Mookerjee, B
Bhujwalla, ZM
Sutter, CH
Artemov, D
Zeng, QW
Dillehay, LE
Madan, A
Semenza, GL [1 ]
Bedi, A
机构
[1] Johns Hopkins Univ, Sch Med, Inst Med Genet, Dept Pediat, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21287 USA
[4] Johns Hopkins Univ, Sch Med, Inst Med Genet, Dept Med, Baltimore, MD 21287 USA
[5] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
关键词
p53; hypoxia-inducible factor-1 (HIF-1); angiogenesis; vascular endothelial growth factor (VEGF); hypoxia; cancer;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The switch to an angiogenic phenotype is a fundamental determinant of neoplastic growth and tumor progression. We demonstrate that homozygous deletion of the p53 tumor suppressor gene via homologous recombination in a human cancer cell line promotes the neovascularization and growth of tumor xenografts in nude mice. We find that p53 promotes Mdm2-mediated ubiquitination and proteasomal degradation of the HIF-1 alpha subunit of hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that regulates cellular energy metabolism and angiogenesis in response to oxygen deprivation. Loss of p53 in tumor cells enhances HIF-1 alpha levels and augments HIF-1-dependent transcriptional activation of the vascular endothelial growth factor (VEGF) gene in response to hypoxia. Forced expression of HIF-1 alpha in p.53-expressing tumor cells increases hypoxia-induced VEGF expression and augments neovascularization and growth of tumor xenografts. These results indicate that amplification of normal HIF-1-dependent responses to hypoxia via loss of p53 function contributes to the angiogenic switch during tumorigenesis.
引用
收藏
页码:34 / 44
页数:11
相关论文
共 67 条
[1]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[2]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[3]   Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].
Bergers, G ;
Javaherian, K ;
Lo, KM ;
Folkman, J ;
Hanahan, D .
SCIENCE, 1999, 284 (5415) :808-812
[4]   p53 inhibits hypoxia-inducible factor-stimulated transcription [J].
Blagosklonny, MV ;
An, WG ;
Romanova, LY ;
Trepel, J ;
Fojo, T ;
Neckers, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :11995-11998
[5]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[6]  
Bouvet M, 1998, CANCER RES, V58, P2288
[7]  
Brown JM, 1998, CANCER RES, V58, P1408
[8]  
BROWN LF, 1996, CONTROL ANGIOGENESIS
[9]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[10]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490